Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? Yes

被引：8
|
作者：
Scully, MF [1 ]
机构：
[1] Mem Univ Newfoundland, Hlth Sci Ctr, Fac Med, St John, NF, Canada
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2005年 / 3卷 / 05期
关键词：
D O I：
10.1111/j.1538-7836.2005.01396.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：840 / 841
页数：2
相关论文
共 50 条
  • [1] Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No
    Rickles, FR
    Marder, VJ
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (05) : 842 - 843
  • [2] Anticoagulant Therapy in Patients with Antiphospholipid Syndrome
    Capecchi, Marco
    Abbattista, Maria
    Ciavarella, Alessandro
    Uhr, Mario
    Novembrino, Cristina
    Martinelli, Ida
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [3] Sustained Moderate Intensity Levels of Oral Anticoagulant Therapy and the Rate of Recurrent Thrombosis in Patients with Primary Antiphospholipid Syndrome
    Turrent, Alonso
    Hernandez-Molina, Gabriela
    Cabral, Antonio R.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S5 - S6
  • [4] Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome
    Mecki Isert
    Wolfgang Miesbach
    Gundolf Schüttfort
    Yvonne Weil
    Vanessa Tirneci
    Alexander Kasper
    Adele Weber
    Edelgard Lindhoff-Last
    Eva Herrmann
    Birgit Linnemann
    Annals of Hematology, 2015, 94 : 1291 - 1299
  • [5] Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome
    Isert, Mecki
    Miesbach, Wolfgang
    Schuettfort, Gundolf
    Weil, Yvonne
    Tirneci, Vanessa
    Kasper, Alexander
    Weber, Adele
    Lindhoff-Last, Edelgard
    Herrmann, Eva
    Linnemann, Birgit
    ANNALS OF HEMATOLOGY, 2015, 94 (08) : 1291 - 1299
  • [6] Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment
    Castellino, G
    Cuadrado, MJ
    Godfrey, T
    Khamashta, MA
    Hughes, GRV
    ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (05) : 527 - 530
  • [7] Quality of life in patients with antiphospholipid syndrome is related to disease burden and anticoagulant therapy
    Hernandez-Molina, Gabriela
    Gonzalez-Perez, Itzel
    Pacheco-Molina, Carlos
    Cabral, Antonio R.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (06) : 755 - 759
  • [8] Quality of Life in Patients with Antiphospholipid Syndrome Is Related to Disease Burden and Anticoagulant Therapy
    Hernandez-Molina, Gabriela
    Gonzalez-Perez, Itzel
    Pacheco, Carlos
    Cabral, Antonio R.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [9] Failure of aggressive anticoagulant therapy in catastrophic antiphospholipid syndrome
    Zoli, A
    D'Agostino, MA
    Pompa, A
    Altomonte, L
    Mirone, L
    Magaró, A
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (01) : 113 - 113
  • [10] Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome
    Crowther, MA
    THROMBOSIS RESEARCH, 2004, 114 (5-6) : 443 - 446
12345